Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abramson M, Puy R, Weiner J (2003) Allergen immunotherapy for asthma (Cochrane Review). Cochrane Libr. https://doi.org/10.1002/14651858.CD001186
Adkinson NF, Eggleston PA, Eney D, Goldstein EO, Schuberth KC et al (1997) A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 336:324–331
Arvidsson MB, Löwhagen O, Rak S (2002) Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 109:777–783
BKK Dachverband (2019) Stellungnahme des BKK Dachverbandes e.V. vom 04. April 2019 zum Entwurf eines Gesetzes für mehr Sicherheit in der Arzneimittelversorgung (GSAV) BT-Drs. 19/8753. https://www.bkk-dachverband.de/fileadmin/user_upload/20190404_BKK_DV_Stellungnahme_GE_GSAV.pdf
Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brociek W, Wichel FB (1988) Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 82:971–977
Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al (1999) Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 54:249–260
Bundesministerin für Gesundheit (2008): Verordnung über die Ausdehnung der Vorschriften über die Zulassung der Arzneimittel auf Therapieallergene, die für einzelne Personen auf Grund einer Rezeptur hergestellt werden, sowie über Verfahrensregelungen der staatlichen Chargenprüfung (Therapieallergene-Verordnung) vom 7. November 2008. Bundesgesetzblatt 2008 Teil I Nr. 51, Bonn 13. November 2008, Seite 2177–2178. Internet: www.bgbl.de/Xaver/start.xav?startbk=Bundesanzeiger_BGBl
Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001936.pub2
Calderon M, Mösges R, Hellmich M, Demoly P (2010) Towards evidence-based medicine in specific grass pollen immunotherapy. Allergy 65:420–434
Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR (2006) Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118:434–440
Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR (2008) Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 121:512–518
DAZ-Online (2016) Epipen in den USA − Lebenswichtiges Arzneimittel wird unbezahlbar. https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/08/31/lebenswichtiges-arzneimittel-wird-unbezahlbar
Demoly P, Emminger W, Rehm D, Backer V, Tommerup L, Kleine-Tebbe J (2016) Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol 137:444–451
Devillier P, Dreyfus JF, Demoly P, Calderón MA (2014) A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med 12:71. https://doi.org/10.1186/1741-7015-12-71
Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci Ö, Mosges R, Palomares O, Pfaar O, Smolinska S, Sokolowska M, Asaria M, Netuveli G, Zaman H, Akhlaq A, Sheikh A (2017a) Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy 72:1825–1848
Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Oude Elberink JN, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Ollert M, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Asaria M, Netuveli G, Sheikh A (2017b) Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 72:342–365
Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, Andre C, de Beaumont O, Melac M (2007) Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grasspollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 120:1338–1345
Durham SR, Walker SM, Varga EM, Jacobson MR, O’Brian F, Noble W et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468–475
Englert L, May S, Kaul S, Vieths S (2012) Die Therapieallergene-Verordnung – Hintergrund und Auswirkungen. Bundesgesundheitsbl 55:351–357
Guez S, Vatrinet C, Fadel R, Andre C (2000) House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 55:369–375
Hoff M, Krail M, Kästner M, Haustein D, Vieths S (2002) Fusarium culmorum causes strong degradation of pollen allergens in extract mixtures. J Allergy Clin Immunol 109:96–101
James C, Bernstein DI (2017) Allergen immunotherapy: an updated review of safety. Curr Opin Allergy Clin Immunol 17:55–59
Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O’Hehir R, Kleine-Tebbe J, Muraro A, Lack G, Larenas D, Levin M, Nelson H, Pawankar R, Pfaar O, van Ree R, Sampson H, Santos AF, Du Toit G, Werfel T, Gerth van Wijk R, Zhang L, Akdis CA (2015) International consensus on allergy immunotherapy. J Allergy Clin Immunol 136:556–568
Kassenärztliche Vereinigung Baden-Württemberg (2015) SCIT und SLIT: Neue S2k-Leitlinie nimmt Präparate in den Fokus. Verordnungsforum 34, S 8–15
Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP (2013) Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol 132:353–360
Klimek I, Vogelberg C, Hamelmann E (2015) Allergenspezifische Immuntherapie: interessante Bewertungen und korrekturbedürftige Fehleinschätzungen. Allergo J 24:68–71
Larenas-Linnemann D (2016) How does the efficacy and safety of Oralair® compare to other products on the market? Ther Clin Risk Manag 12:831–850
Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D (2001) Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesunheitsbl – Gesundheitsforsch – Gesundheitsschutz 44:709–718
Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C, Barton P, Dretzke J (2013) A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 17:1–322
Mellerup MT, Hahn GW, Poulsen LK, Malling HJ (2000) Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 30:1423–1429
Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L et al (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol 109:251–256
Nelson HS (2007) Allergen immunotherapy: where is it now? J Allergy Clin Immunol 119:769–779
Olsen OT, Larsen KR, Jacobsan L, Svedsen UG (1997) A 1-year placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults. Allergy 52:853–859
O’Neill SM, Forsyth A (1988) Urticaria. Prescr J 28:14–20
Paul-Ehrlich-Institut (2019a) Therapieallergene-Verordnung trägt Früchte. https://www.pei.de/DE/infos/presse/pressemitteilungen/2018/13-therapieallergene-verordnung-traegt-fruechte.html
Paul-Ehrlich-Institut (2019b) Zugelassene Therapie-Allergene. https://www.pei.de/DE/arzneimittel/allergene/therapie-allergene/therapie-allergene-node.html
Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, Friedrichs F, Fuchs T, Hamelmann E, Hartwig-Bade D, Hering T, Hutteger I, Jung K, Klimek L, Kopp MV, Merk H, Rabe U, Saloga J, Schmid-Grendelmeier P, Schuster A, Schwerk N, Sitter H, Umpfenbach U, Wedi B, Wöhrl S, Worm M, Kleine-Tebbe J (2014) Leitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen. Allergo J Int 23:282–319
Pichler CE, Marquardsen A, Sparholt S, Lowenstein H, Bircher A, Bischof M, Pichler WJ (1997) Specific immunotherapy with Dermatophagoides ptheronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 52:274–283
Radulovic S, Wilson D, Calderon M, Durham S (2011) Systematic reviews of sublingual immunotherapy (SLIT). Allergy 66:740–752
Rietschel E, Hutegger I, Lange L, Urbanek R (2013) Anaphylaxie – Diagnostisches und therapeutisches Vorgehen. Med Klin Intensivmed Notfmed 108:239–249
Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, Halken S, Larenas-Linnemann D, Pawankar R, Pitsios C, Sheikh A, Worm M, Arasi S, Calderon MA, Cingi C, Dhami S, Fauquert JL, Hamelmann E, Hellings P, Jacobsen L, Knol EF, Lin SY, Maggina P, Mösges R, Oude Elberink JNG, Pajno GB, Pastorello EA, Penagos M, Rotiroti G, Schmidt-Weber CB, Timmermans F, Tsilochristou O, Varga EM, Wilkinson JN, Williams A, Zhang L, Agache I, Angier E, Fernandez-Rivas M, Jutel M, Lau S, van Ree R, Ryan D, Sturm GJ, Muraro A (2018) EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy 73:765–798
Scaparrotta A, Attanasi M, Petrosino MI, Di Filippo P, Di Pillo S, Chiarelli F (2015) Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis. Drug Des Devel Ther 9:5897–5909
Valsecchi R, di Landro A, Pansera B, Cainelli T (1994) Contact dermatitis from a gel containing dimethindene maleate. Contact Dermatitis 30:248–249
Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, Ljørring C, Riis B, de Blay F (2016) Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA 315:1715–1725
Wheatley LM, Togias A (2015) Clinical practice. Allergic rhinitis. N Engl J Med 372:456–463
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Zawinell, A., Schwabe, U. (2019). Antiallergika. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-59046-1_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59045-4
Online ISBN: 978-3-662-59046-1
eBook Packages: Medicine (German Language)